Human pregnancy requires the coordinated function of multiple tissues in both mother and fetus and has 36 evolved in concert with major human adaptations. As a result, pregnancy-associated phenotypes and 37 related disorders are genetically complex and have likely been sculpted by diverse evolutionary forces. 38 However, there is no framework to comprehensively evaluate how these traits evolved or to explore the 39 relationship of evolutionary signatures on trait-associated genetic variants to molecular function. Here we 40
hypotheses about how these genomic regions contribute to sPTB risk. In summary, we introduce an 48 approach for inferring the spectrum of evolutionary forces acting on genomic regions associated with 49 complex disorders. When applied to sPTB-associated genomic regions, this approach both improves our 50 understanding of the potential roles of these regions in pathology and illuminates the mosaic nature of 51 evolutionary forces acting on genomic regions associated with sPTB. 52
INTRODUCTION
sculpted specific genes involved in human birth timing, we lack a comprehensive examination of how 79 diverse evolutionary forces have influenced genomic regions involved in sPTB. 80
The recent availability of sPTB-associated genomic regions from large genome-wide association studies 81 (GWAS) 32 coupled with advances in measuring evidence for diverse evolutionary forces-including 82 balancing selection 33 , positive selection 34 , and purifying selection 35 from human population genomic 83 variation data-present the opportunity to comprehensively survey how evolution has shaped sPTB-84 associated genomic regions. To achieve this, we developed an approach that identifies evolutionary forces 85 that have acted on genomic regions associated with a complex trait and compares them to appropriately 86 matched control regions. Our approach innovates on current methods by evaluating the impact of multiple 87 different evolutionary forces on trait-associated genomic regions while accounting for genomic 88 architecture-based differences in the expected distribution for each of the evolutionary measures. 89
Application of our approach to 215 sPTB-associated genomic regions showed significant evidence for at 90 least one evolutionary force in 120 regions. Furthermore, we identified functional links to sPTB and other 91 pregnancy phenotypes for representative genomic regions exhibiting evidence for each evolutionary 92 force. These results suggest that a mosaic of evolutionary forces likely influenced human birth timing, 93 and that evolutionary analysis can assist in interpreting the role of specific genomic regions in disease 94 phenotypes. 95
RESULTS & DISCUSSION 96
Evaluating the significance of evolutionary measures by accounting for genomic architecture 97
In this study, we compute diverse evolutionary measures on sPTB-associated genomic regions to infer the 98 action of multiple evolutionary forces (Table 1) . While various methods to detect signatures of 99 evolutionary forces exist, many of them lack approaches for determining statistically significant 100 observations or rely on the comparison to the distribution of the measure when applied genome-wide 36, 37 . 101 Furthermore, population level attributes, such as minor allele frequency (MAF) and linkage disequilibrium (LD), influence the power to detect both evolutionary signatures [38] [39] [40] and GWAS 103 associations 41 . Thus, interpretation and comparison of different evolutionary measures is challenging, 104 especially when the regions under study do not reflect the genome-wide background. 105
Here we develop an approach that derives a matched null distribution accounting for MAF and LD for 106 each evolutionary measure and set of regions. We generate 5,000 control region sets that each match the 107 trait-associated regions on these attributes (Methods). Then, to calculate an empirical p-value and z-score 108 for each evolutionary measure and region of interest, we compare the median values of the evolutionary 109 measure for variants in the sPTB-associated genomic region to the same number of variants in the 110 corresponding matched control regions. This enables comparison across evolutionary measures and 111 genomic regions ( Figure 1A , Methods). 112 113 114 Table 1 : Evolutionary measures computed on sPTB-associated genomic regions with the corresponding evolutionary signature used to infer the evolutionary force and the associated timescale. GERP: Genomic evolutionary rate profiling. iHS: integrated haplotype score. XP-EHH: cross-population extended haplotype homozygosity (EHH). iES: integrated sitespecific EHH. TMRCA: time to most recent common ancestor derived from ARGweaver. Alignment block age was calculated using 100-way multiple sequence alignments to determine the oldest most recent common ancestor for each alignment block.
Measures
Evolutionary 
Across species
We used this approach to evaluate the evolutionary forces acting on genomic regions associated with 115 sPTB. First, we identified all variants nominally associated with sPTB (p<10E-4) in the largest available 116 GWAS 32 and grouped variants into regions based on high LD (r 2 >0.9). It is likely that many of these 117 nominally associated variants affect sPTB risk, but did not reach genome-wide significance due to factors 118 limiting the statistical power of the GWAS 32 . Therefore, we assume that many of the variants with sPTB-119 associations below this nominal threshold contribute to the genetic basis of this trait. This identified 215 120 independent sPTB-associated genomic regions, which we refer to by the lead variant (SNP or indel with 121 the lowest p-value in that region). 122
For each of the 215 sPTB-associated genomic regions, we generated control regions as described above. 123
The match quality per genomic region, defined as the fraction of sPTB variants with a matched variant 124 averaged across all control regions, is Our approach to test for signatures of different evolutionary forces has many advantages. Comparing 138 evolutionary measures against a null distribution that accounts for MAF and LD enables us to increase the 139 sensitivity with which we can infer the action of evolutionary forces on sets of genomic regions that differ 140 in their genome architectures. In addition, the lead SNPs assayed in a GWAS are often not the causal 141 variant, so by testing both the lead SNPs and those in LD when evaluating a genomic region for 142 evolutionary signatures, we are able to better represent the trait-associated evolutionary signatures 143 compared to other methods that evaluate only the lead variant 42 or all variants, including those not 144 associated with the trait, in a genomic window 43 ( Supplementary Table 1 ). Finally, our approach uses an 145 empirical framework that leverages the strengths of diverse existing evolutionary measures. 146
Genomic regions associated with sPTB exhibit signatures of diverse modes of selection. 147
To gain insight into the modes of selection that have acted on sPTB-associated genomic regions, we 148 Previous literature on complex genetic traits 44-46 and pregnancy disorders 25,29,30,47,48 supports the finding 159 that multiple modes of selection have acted on sPTB-associated genomic regions. Unlike many of these 160 previous studies that tested only a single mode of selection, our approach tested multiple modes of 161 selection. Of the 215 genomic regions we tested, 9% had evidence of conservation, 5% had evidence of 162 excess population differentiation, 4% had evidence of accelerated evolution, 4% had evidence of long-163 term balanced polymorphisms, and 34% had evidence of other combinations. From these data we infer that negative selection, local adaptation, positive selection, and balancing selection have all acted on 165 genomic regions associated with sPTB, highlighting the mosaic nature of the evolutionary forces that 166 have shaped this trait. In addition to differences in evolutionary measures, variants in these groups also 167 exhibited differences in their functional effects, likelihood of influencing transcriptional regulation, 168 frequency distribution between populations, and effects on tissue-specific gene expression ( Figure 3 are not known to be associated with expression changes ( Figure 4D ). 183
The sPTB-associated genomic region in the 3' UTR of the gene TET3 has significant values for 184 LINSIGHT, GERP, and PhastCons100 (Figure 2 ). The G allele of rs6546891 is associated with a 185 nominally increased risk of sPTB in European ancestry individuals (OR: 1.13; adjusted p-value: 5.4x10 -186 gene/tissue pairs: most notably this variant is associated with the expression of the hypothetical protein 190 LOC730240 in the uterus, ovary, vagina, and brain as well as the expression of N-acetyltransferase 8 191 (NAT8) in the testis. The conservation detected at this locus suggests that disruptions in NAT8 or TET3 192 are likely to be deleterious. 193
The genes TET3 and NAT8 are both linked to gestation and pregnancy outcomes. In mice, TET3 affects 194 epigenetic reprogramming in oocytes and zygotes, is required for neonatal growth, and depletion of TET3 195 in female mice results in reduced fecundity 49,50 . In humans, TET3 expression was detected in the villus 196 cytotrophoblast cells in the first trimester as well as in maternal decidua of placentas 51 . Expression 197 profiling showed elevated TET3 transcripts in preeclamptic placentas and in pregnancies ending with the 198 birth of a newborn that is small for gestational age (SGA) 52 . TET3 is also hypothesized to play a role in 199 the link between preterm birth and the risk of neurodevelopmental disorders due to the gene's role in 200 epigenetic regulation 53 . NAT8, which is involved in acetylation of histones, may also play a role in 201 epigenetic changes during pregnancy 54 . The strong sequence conservation of the region containing 202 variant rs6546891 is consistent with previous findings that negative selection is the dominant mode of 203 selection for TET3 55 . More broadly, these findings suggest that several sPTB-associated genomic regions 204 have experienced negative selection, consistent with previous studies 42, 56 . 205
Group B: Population Differentiation/Population-specific Adaptation 206
Group B (clusters B1 and B2) contained variants with a higher than expected differentiation (F ST ) 207 between pairs of human populations ( Figure 2 ). There were 10 sPTB-associated genomic regions in this 208 group, which contain 53 variants. Most variants in this group are intronic (38/53) while the rest are 209 intergenic (14/53) or located within 5000bp upstream of a gene (1/53) ( Figure 3A ). One variant 210 (rs3897712) may be involved in regulating transcription factor binding ( Figure 3B ), but is not a known 211 eQTL. For the remaining variants, the majority are an eQTL in at least one tissue (29/52; Figure 3D ). The 212 derived allele frequency in cluster B1 is high in East Asian populations and very low in African and 213 European populations ( Figure 3C ). We found that 3 of the 10 lead variants have higher risk allele 214 frequencies in African compared to European or East Asian populations. This is noteworthy because the 215 rate of PTB is twice as high among black women compared to white women in the United States 57,58 . 216
These three variants are associated with expression levels of the genes SLC33A1, LOC645355, and GC, 217 respectively. 218
The six variants within the sPTB-associated region near GC, Vitamin D Binding Protein, are of particular 219 interest. The lead variant is rs222016. The G allele of this lead variant (rs222016) has a higher frequency 220 in African populations, is the ancestral allele, and is associated with increased risk of sPTB (European 221 cohort, OR: 1.15; adjusted p-value 3.58x10-5; Figure 4B ) 32 . This variant has also been associated with 222 vitamin D levels and several other disorders; for example, in individuals with ankylosing spondylitis the 223 G allele (risk for sPTB) is associated with increased risk of developing peripheral arthritis 59 . This variant 224 is also associated with high baseline D3 levels in serum but is not associated with reduced risk of D3 225 insufficiency 60 . There is also evidence that vitamin D levels prior to delivery are associated with sPTB, 61-226 64 that levels of GC in cervico-vaginal fluid may help predict sPTB 65,66 , and that vitamin D deficiency 227 may contribute to racial disparities in birth outcomes 67,68 . Specifically, vitamin D deficiency may 228 contribute to potential risk for preeclampsia among Hispanic and African American women 69 . The 229 population-specific differentiation associated with the variant rs222016 is consistent with the differential 230 evolution of the vitamin D system between populations-likely in response to different environments and 231 associated changes in skin pigmentation 70,71 . Our results provide evolutionary context for the link between 232 vitamin D and pregnancy outcomes 72 and suggest a role for variation in the gene GC in the ethnic 233 disparities in pregnancy outcomes. 234 Figure 3A ). Additionally, 16 variants in this group are likely to affect transcription factor binding 242 (regulomeDB score of 1 or 2; Figure 3B ). Consistent with this finding, of the 216 variants tested in GTEx, 243 167 are associated with expression of at least one gene in one tissue ( Figure 3C) . is an actin-binding protein involved in cell migration and invasion [82] [83] [84] . CTTN was shown to be expressed 264 in the decidual cells and spiral arterioles as well as localize to the trophoblast cells during early 265 pregnancy-suggesting a role for CTTN in cytoskeletal remodeling of the maternal-fetal interface during 266 early pregnancy 85, 86 . While neither CTTN nor PPFIA1 have been implicated in sPTB, they are both linked 267 to cell adhesion and there is evidence that decreased adherence of maternal and fetal membrane layers is 268 involved in parturition 87 . The accelerated evolution associated with variants in this region is also 269 consistent with the rapid diversification of the placenta within eutherians 88-90 . While the proteins CTTN 270 and PPFIA1 are highly conserved across mammals, the accelerated evolution detected in association with 271 rs1061328 may be linked to the functionally important and diverse splice variants of both proteins 74,91 . 272 Accelerated evolution has previously been detected in the birth timing-associated genes FSHR 47 and 273 PLA2G4C 92 . It has been hypothesized that human and/or primate-specific adaptations, such as bipedalism, 274 have resulted in the accelerated evolution of birth-timing phenotypes along these lineages 2,93,94 . 275 Accelerated evolution has also been implicated in other complex disorders-especially those like 276 schizophrenia 95,96 and autism 97 which affect the brain, another organ that is thought to have undergone 277 adaptive evolution in the human lineage. 278
Group D: Balanced Polymorphism/Balancing Selection 279
Variants in Group D generally had higher than expected values of beta score or an older allele age than 280 expected, which is consistent with evolutionary signatures of balancing selection (Figure 2 ). Beta score is 281 a measure of long-term balancing selection within the human lineage 33 . Allele age is measured as the time 282 to most recent common ancestor (TMRCA) in thousands of generations since present based on 54 283 unrelated individuals, which was obtained from ARGweaver 34 . There are nine genomic regions in group 284 D, of which three have a significantly (p<0.05) higher beta score than expected, three have a significantly 285 older (p<0.05) than expected TMRCA, and three have older TMRCA but are not significant. The derived 286 alleles in this group have an average derived allele frequency across all populations of 0.44 ( Figure  287 3C).There are 292 variants in this group; nearly all of these variants are intronic (274/292; Figure 3A) and 288 there is evidence of regulatory binding for 11 variants (regulome DB score of 1 or 2; Figure 3B ). GTEx 289 analysis supports the regulatory role of a number of variants-266 of 271 variants are an eQTL in at least 290 one tissue ( Figure 3D ). For the genomic region associated with the lead variant rs10932774 there are 26 291 additional variants which are eQTLs for an average of 80 unique tissue/gene combinations. eQTL 292 analysis detects at least one expression change in the uterus in all but five of these variants. 293
The variant rs10932774 is located within the 2 nd of nine introns in the gene PNKD (also known as 294 myofibrillogenesis regulator 1), which is the causal gene in the neurological movement disorder 295 paroxysmal nonkinesiogenic dyskinesia (PNKD) 98 . This variant has a significant value for both TMRCA 296 and beta score. The G allele at this locus is associated with an increased risk of sPTB (OR: 1.11, adjusted 297 p-value 8.85x10 -5 ) 32 and is the major allele in all the populations examined ( Figure 4D ). Supporting the 298 interpretation of long-term balancing selection, this polymorphism is also present in the great apes. This 299 variant is associated with the expression of five genes in 43 tissues for a total of 73 gene/tissue 300 combinations in the GTEx database. Additionally, the PNKD gene is up-regulated in severely 301 preeclamptic placentas 99 and in PNKD patients pregnancy is associated with changes in the frequency or 302 severity of PNKD attacks [100] [101] [102] 
. Expression changes in the Transmembrane BAX Inhibitor Motif-303
Containing Protein 1 gene (TMBIM1) and the Actin Related Protein 2/3 Complex Subunit 2 gene 304 (ARPC2) are also associated with this variant. TMBIM1 is a cell death regulator 103 with no known role in 305 pregnancy. Methylation of TMBIM1, however, is altered in the offspring of mothers with Type 1 306 Diabetes 104 . The gene ARPC2 is a subunit of the Arp2/3 complex which controls actin polymerization and 307 is also highly conserved 105,106 . The complex is important for early embryo development and 308 preimplantation in pigs and mice 107,108 . ARPC2 expression has been identified in the BeWo trophoblastic 309 cell line used to investigate placental function 109 and is subject to RNA editing in placentas associated 310 with intrauterine growth restriction/small for gestational age (SGA) 110 . Overall, genes associated with the 311 variant rs10932774 (PNKD, TMBIM1 and ARPC2) show long-term evolutionary conservation consistent 312 with a signature of balancing selection and prior research suggests links to pregnancy through a variety of 313 mechanisms. The identification of balancing selection acting on sPTB-associated genomic regions is 314 consistent with the critical role of the immune system, which often experiences balancing 315 selection 33, 111, 112 , in establishing and maintaining pregnancy 113 . 316
The largest group of variants consists of a variety of evolutionary signatures 317
The final group, group E, contained the remaining genomic regions in clusters E1, E2, E3 and E4 and was 318 associated with a broad range of evolutionary signatures (Figure 2) . At least one variant in group E had a 319 significant p-value for every evolutionary measure except for alignment block age. While this group does 320 not reflect the action of a single evolutionary measure or force, over half of the lead variants (39/73) had a 321 significant p-value (p<0.05) for either GERP or XP-EHH. This group also contained 23 of the 33 322 genomic regions with a z-score (|z|>1.5) for population specific iHS (Supp. Table 2 ). These genomic 323 regions contained a total of 444 linked variants of which 242 are intronic variants, 178 are intergenic 324 variants and the remaining 24 variants are upstream and downstream variants ( Figure 4A ). This group 325 also contains 19 variants that are likely to affect binding (regulomeDB score of 1 or 2; Fig. 4b ). The 326 majority of the derived alleles in this group are minor in Europeans (313/444; Figure 4C ). There are also 327 143 variants identified as eQTLs, including 16 expression changes for genes in the uterus (all associated 328 with the variant rs12646130; Figure 4D ). Interestingly, this group contained variants linked to the 329 EEFSEC, ADCY5, and WNT4 genes, which have been previously associated with gestational duration or 330 preterm birth 32 . 331
The variant rs8126001 is located in the 5' UTR of the opioid related nociception receptor 1 or nociception 332 opioid receptor (OPRL1 or NOP-R) gene which may be involved in myometrial contractions during 333 delivery 114,115 . This variant has signatures of positive selection as detected by the integrated haplotype 334 score (iHS) within the African population (Supp. Table 2 ). The T allele at this locus is protective for 335 sPTB (effect: 0.896; adjusted p-value 4.04x10 -5 ) 32 and arose in the human lineage. The protective allele 336 has a relatively low frequency in the African population and is located in a region with low haplotype 337 diversity ( Figure 4E ). This locus is also associated with expression of OPRL1 in tissues like the brain, 338 aorta and esophagus ( Figure 4E ). The gene OPRL1 is a receptor for the endogenous peptide nociceptin 339 (N/OFQ) which is derived from prenocicpetin (PNOC). There is evidence that nociception and its 340 receptor may play a role in pregnancy. N/OFQ and PNOC were detected in rat and human pregnant 341 myometrial tissues 32 and OPRL1 was detected in rat myometrium. 114, 116 Additionally, PNOC mRNA 342 levels are significantly higher in preterm uterine samples in humans and can elicit myometrial relaxation 343 in vitro 115, 116 . It is therefore likely that nociceptin and OPRL1 are involved in the perception of pain 344 during delivery and the initiation of delivery. While a single mode of evolution does not characterize 345 group E, the high frequency of genomic regions with significant XP-EHH or population specific iHS 346 values (40/73 genomic regions) suggests that population-specific evolutionary forces may be at play in 347 this group. The sPTB GWAS and population-specific evolutionary measures were conducted in women of 348
European ancestry but we know that sPTB risk varies with genomic background 117,118 . Therefore, this 349 group also suggests that individual populations experience a different mosaic of evolutionary forces on 350 pregnancy phenotypes. 351
CONCLUSIONS 352
In this study, we developed an approach to test for signatures of diverse evolutionary forces and applied it 353 to sPTB-associated genomic regions. This approach explicitly accounts for MAF and LD in trait-354 associated genomic regions. We find evolutionary conservation, excess population differentiation, 355 accelerated evolution, and balanced polymorphisms in 120 of the 215 sPTB-associated genomic regions. 356
Annotation of these regions using existing databases and literature suggest plausible functional links to 357 pregnancy phenotypes, bolstering our confidence that these regions contribute to sPTB risk. These results 358 suggest that no single evolutionary force is responsible for shaping the genetic architecture of sPTB; 359 rather, sPTB has been influenced by a diverse mosaic of evolutionary forces. We hypothesize that the 360 same is likely to be true of other complex human traits and disorders; future investigations that test for 361 signatures of multiple evolutionary forces, such as ours, promise to elucidate the degree to which the 362 landscape of evolutionary forces varies across disorders. 363
METHODS 364

Deriving independent genomic regions associated with sPTB from GWAS summary statistics 365
To evaluate evolutionary history of sPTB on distinct regions of the human genome, we identified 366 genomic regions from the GWAS summary statistics. Using PLINK1.9b 367 (pngu.mgh.harvard.edu/purcell/plink/) 102 , the top 10,000 variants associated with sPTB from Zhang et. 368 al. 31 were clumped based on LD using default settings except requiring a p-value ≤ 10E-4 for lead 369 variants and variants in LD with lead variants. We used this liberal p-value threshold to increase the 370 number of sPTB-associated variants evaluated. Although this will increase the number of false 371 positive variants associated with sPTB, we anticipate that these false positive variants will not 372 have statistically significant evolutionary signals using our approach to detect evolutionary 373 forces. This is because the majority of the genome is neutrally evolving and our approach aims to 374 detect deviation from this genomic background. Additionally, it is possible that the lead variant 375 (variant with the lowest p-value) could tag the true variant associated with sPTB within an LD block. 376 Therefore, we defined an independent sPTB-associated genomic region to include the lead and LD 377 (r 2 >0.9, p-value <= 10E-4) sPTB variants. This resulted in 215 independent lead variants within an sPTB-378 associated genomic region. 379
Creating matched control regions for each sPTB-associated genomic regions 380
We detected evolutionary signatures at genomic regions associated with sPTB by comparing them to 381 matched control sets. Since evolutionary measures are influenced by LD and allele frequencies and these 382 also influence power in GWAS, we generated control regions matched for these attributes for observed 383 sPTB-associated genomic regions. First, for each lead variant we identified 5,000 control variants 384 matched on minor allele frequency (+/-5%) , LD (r 2 >0.9, +/-10% number of LD buddies), gene density 385 (+/-500%) and distance to nearest gene (+/-500%) using SNPSNAP 119 , which derives controls variants 386 from a quality controlled phase 3 100 Genomes (1KG) data, with default settings for all other parameters and the hg19/GRCh37 genome assembly. For each control variant, we randomly selected an equal 388 number of variants in LD (r 2 >0.9) as sPTB-associated variants in LD with the corresponding lead variant. 389
If no matching control variant existed, we relaxed the LD required to r 2 =0.6. If still no match was found, 390
we treated this as a missing value. For all LD calculations, control variants and downstream evolutionary 391 measure analyses, the European super-population from phase 3 1KG 120 was used after removing duplicate 392 variants. 393
Evolutionary measures 394
To characterize the evolutionary dynamics at each sPTB-associated region, we sPTB-associated region and evolutionary measure. We first marked any control set that did not match at 407 least 90% of the required variants for a given sPTB-associated region, then any sPTB-associated region 408 with ≥ 60% marked control regions were removed for that specific evolutionary measure. iHS was not 409 included in Figure 2 because of large amounts of missing data for up to 50% of genomic regions 410 evaluated.
Detecting significant differences in evolutionary measures by comparing to control distributions 412
For each sPTB-associated genomic region for a specific evolutionary measure, we took the median value 413 of the evolutionary measure across all its variants and compared it to the distribution of median values 414 from the corresponding control regions. Statistical significance for each sPTB-associated region was 415 evaluated by comparing the median value of the evolutionary measure to the distribution of the median 416 value of the control regions. To obtain the p-value, we calculated the number of control regions with a 417 median value that are equal to or greater the median value for the PTB region. Since allele age (TMRCA 418 from ARGweaver), PhyloP, and alignment block age are bi-directional measures, we calculated two-419 tailed p-values; all other evolutionary measures used one-tailed p-values. To compare evolutionary 420 measures whose scales differ substantially, we calculated a z-score for each region per measure. These z-421 scores were hierarchically clustered across all regions and measures. Clusters were defined by a branch 422 length cutoff of seven. These clusters were then grouped and annotated by the dominant evolutionary 423 measure through manual inspection to highlight the main evolutionary trend(s). 424
Annotation of variants in sPTB-associated regions 425
To understand functional differences between groups and genomic regions we collected annotations for 426 variants in sPTB-associated regions from publicly available databases. Evidence for regulatory function 427 for individual variants was obtained from RegulomeDB v1.1 (accessed 1/11/19) 125 . From this we 428 extracted the following information: total promotor histone marks, total enhancer histone marks, total 429 DNase 1 sensitivity, total predicted proteins bound, total predicted motifs changed, and regulomeDB 430 score. Variants were identified as expression quantitative trait loci (eQTLs) using the Genotype-Tissue 431 Expression (GTEx) project data (dbGaP Accession phs000424.v7.p2 accessed 1/15/19). Variants were 432 mapped to GTEx annotations based on rs number and then the GTEx annotations were used to obtain 433 eQTL information. For each locus, we obtained the tissues in which the locus was an eQTL, the genes for 434 which the locus affected expression (in any tissue), and the total number times the locus was identified as 435 an eQTL. Functional variant effects were annotated with the Ensembl Variant Effect Predictor (VEP; accessed 1/17/19) based on rs number 126 . Population-based allele frequencies were obtained from the 437 1KG phase3 data for the African (excluding related African individuals; Supplementary Table 3) 
, East 438
Asian, and European populations 120 . 439
To infer the history of the alleles at each locus across mammals, we created a mammalian alignment at 440 each locus and inferred the ancestral states. That mammalian alignment was built using data from the 441 sPTB GWAS 32 (risk variant identification), the UCSC Table Browser 123 (30 way mammalian alignment), 442 the 1KG phase 3 120 data (human polymorphism data) and the Great Ape Genome project (great ape 443 polymorphisms) 127 -which reference different builds of the human genome. To access data constructed 444 across multiple builds of the human genome, we used Ensembl biomart release 97 128 and the biomaRt R 445 package 129,130 to obtain the position of variants in hg38, hg19, and hg18 based on RefSNP (rs) number 131 . 446
Alignments with more than one gap position were discarded due to uncertainty in the alignment. All 447 variant data were checked to ensure that each dataset reported polymorphisms in reference to the same 448 strand. Parsimony reconstruction was conducted along a phylogenetic tree generated from the TimeTree 449 database 132 . Ancestral state reconstruction for each allele was conducted in R using parsimony estimation 450 in the phangorn package 133 . Five character-states were used in the ancestral state reconstruction: one for 451 each base and a fifth for gap. Haplotype blocks containing the variant of interest were identified using 452 Plink (v1.9b_5.2) to create blocks from the 1KG phase3 data. Binary haplotypes were then generated for 453 each of the three populations using the IMPUTE function of vcftools (v0.1.15.) Median joining 454 networks 134 were created using PopART 135 . 455 
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Data Availability 458
All the data used in this study were obtained from the public domain (see the URLs above) or deposited 459 in a figshare repository to be made public upon publication. 460
Code Availability 461
All scripts used to measure evolutionary signatures and generate figures are publicly accessible in a 462 figshare repository to be made public upon publication. 
